1 Geriatrician for Every 5,000 Patients Over 65. The Math Does Not Work.
Key Facts
- There is approximately 1 geriatrician for every 5,000 Americans aged 65 and older.
- The recommended ratio of geriatricians to patients 65+ is 1:750.
- CMS mandates cognitive impairment detection during every Medicare Annual Wellness Visit.
- Up to 50% of people living with dementia are not formally diagnosed.
This article discusses the challenges geriatricians face due to workforce shortages and increasing demands for cognitive assessments, and how technology can help. There is approximately one geriatrician for every 5,000 Americans aged 65 and older, far from the recommended 1:750 ratio. This shortage, coupled with the CMS requirement for cognitive decline screening for Medicare patients 65+, creates immense pressure.
The Growing Demand for Cognitive Screening
There is a growing demand for cognitive screening due to the high prevalence of undiagnosed cognitive impairment. An estimated 12 million Americans live with mild cognitive impairment (MCI), and 92% are unaware. Undiagnosed dementia affects up to 50% of individuals. While CMS mandates cognitive impairment detection during Annual Wellness Visits, the typical 15-minute primary care visit poses challenges for thorough screening, functional assessments (ADLs/IADLs), and documentation, potentially impacting care quality.
Automation for ADL and IADL Assessments
ADL and IADL assessments can be automated to save time and improve objectivity. Current systems often rely on manual, time-consuming, and subjective processes. GIA™ automates ADL and IADL assessments, gathering data conversationally before the patient visit and writing results to the EHR for review and approval. This saves time, allows for focused patient interaction, and provides a more objective baseline for tracking functional decline.
The Operator's Guide to Multimodal Clinical AI
What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.
GIA™: Extending Your Reach, Enhancing Your Care
GIA™ extends the reach of geriatricians by conducting cognitive screening and functional assessments (ADLs/IADLs) before the patient encounter. GIA documents directly into the EHR and flags concerning results. In under 5 minutes, GIA uses over 2,500 speech biomarkers to deliver results in 60 seconds, with 70.8% accuracy in detecting cognitive decline, 81.6% for depression, and an AUC of 0.97 for Parkinson's. GIA is 510(k) cleared, HIPAA compliant, trained on 46 conditions across 12.3M patients and 27B clinical events, and speaks 92 languages. GIA screens; it does not diagnose. A human-in-the-loop is always required.
Reducing False Positives, Improving Referrals
GIA™ reduces false positives and improves referrals by providing a structured and objective initial assessment. Studies indicate that approximately 4 out of 10 PCP referrals to neurologists are false positives. GIA™ helps reduce inappropriate referrals by providing a more structured and objective initial assessment, directing patients to the right specialists at the right time. This streamlines the referral process, minimizes unnecessary anxiety and healthcare costs, and promotes efficient use of older adult resources.
Conclusion
The shortage of geriatricians is a critical challenge, but it's not insurmountable. By embracing effective platforms like GIA™, we can empower geriatricians to do more for their patients without burning out. Let's work together to bridge the gap and ensure that every older adult receives the complete care they deserve. It’s about empowering you to continue providing exceptional care, with the support you need to thrive. Request a demo to see how GIA can help your practice.
Sources & References
- Centers for Medicare & Medicaid Services (CMS). Annual Wellness Visit requirements, including cognitive impairment detection. cms.gov
- Alzheimer’s Association. 2024 Alzheimer’s Disease Facts and Figures. alz.org/facts
- Scienza Health internal validation data: 12.3M longitudinal PAC/LTC patient records, 27B clinical events.
- U.S. Food & Drug Administration. 510(k) device clearance database. fda.gov
David Kaiser is the Founder and CEO of Scienza Health, where he leads the development of GIA®, a Digital Human® that screens for 46 cognitive and neurological conditions using 2,500+ speech biomarkers in under 5 minutes. The platform is 510(k) cleared, HIPAA compliant, and has been validated on 12.3M patient records and 27B clinical events.
Frequently Asked Questions
How does GIA™ help with the older adult workforce shortage?
GIA™ helps with the older adult workforce shortage by automating time-consuming tasks. It automates cognitive screening and functional assessments (ADLs/IADLs), freeing geriatricians to focus on complex cases, treatment planning, and patient interaction. By streamlining the initial assessment process, GIA™ extends the reach of existing older adult resources, allowing for more patient care without increasing workload.
Is GIA™ intended to replace a geriatrician's clinical judgment?
No, GIA™ is not intended to replace a geriatrician's clinical judgment. GIA screens, she does not diagnose. It is a screening tool designed to augment the expertise of geriatricians by providing data points and flagging potential concerns. The final diagnosis and treatment plan always rest with the clinician. Human-in-the-loop is always required.
How does GIA™ ensure patient privacy and data security?
GIA™ ensures patient privacy and data security through HIPAA compliance and strict data protection protocols. All patient data is encrypted and stored securely. GIA is also 510(k) cleared. The platform is designed to protect sensitive information and maintain patient confidentiality.
The Clinical Signal
Hear the latest episode on clinical AI screening in post-acute care.